DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 55 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,414,000 | -27.4% | 69,978 | +31.7% | 0.00% | 0.0% |
Q2 2021 | $1,948,000 | -5.3% | 53,125 | -31.7% | 0.00% | 0.0% |
Q1 2021 | $2,057,000 | -27.0% | 77,828 | -33.4% | 0.00% | -50.0% |
Q4 2020 | $2,816,000 | +9.6% | 116,833 | -16.0% | 0.00% | 0.0% |
Q3 2020 | $2,570,000 | -30.4% | 139,028 | -4.4% | 0.00% | -33.3% |
Q2 2020 | $3,692,000 | +7.5% | 145,395 | -22.6% | 0.00% | -25.0% |
Q1 2020 | $3,436,000 | +221.4% | 187,757 | +286.9% | 0.00% | +300.0% |
Q4 2019 | $1,069,000 | +1544.6% | 48,531 | +968.7% | 0.00% | – |
Q3 2019 | $65,000 | -4.4% | 4,541 | +5.7% | 0.00% | – |
Q2 2019 | $68,000 | +750.0% | 4,298 | +465.5% | 0.00% | – |
Q4 2018 | $8,000 | +60.0% | 760 | +142.0% | 0.00% | – |
Q3 2018 | $5,000 | -99.4% | 314 | -99.6% | 0.00% | -100.0% |
Q2 2018 | $898,000 | +1051.3% | 73,316 | +218.8% | 0.00% | – |
Q1 2017 | $78,000 | -6.0% | 23,000 | -16.7% | 0.00% | – |
Q4 2016 | $83,000 | -37.6% | 27,609 | +22.1% | 0.00% | – |
Q3 2016 | $133,000 | +79.7% | 22,609 | -8.1% | 0.00% | – |
Q2 2016 | $74,000 | +469.2% | 24,609 | +935.3% | 0.00% | – |
Q1 2016 | $13,000 | +550.0% | 2,377 | +1144.5% | 0.00% | – |
Q4 2015 | $2,000 | 0.0% | 191 | +112.2% | 0.00% | – |
Q2 2014 | $2,000 | – | 90 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|